|
JPH11512708A
(ja)
*
|
1995-09-11 |
1999-11-02 |
オステオアルスリィティス サイエンシズ，インコーポレイテッド |
変形性関節炎を治療するためのプロテインチロシンキナーゼインヒビター
|
|
IL119069A0
(en)
|
1996-08-14 |
1996-11-14 |
Mor Research Applic Ltd |
Pharmaceutical composition comprising tyrphostins
|
|
DE19845372A1
(de)
*
|
1998-10-02 |
2000-04-20 |
Gruenenthal Gmbh |
Verwendung von Katecholderivaten als Proteinaseninhibitoren
|
|
US6153634A
(en)
|
1998-12-17 |
2000-11-28 |
Hoffmann-La Roche Inc. |
4,5-azolo-oxindoles
|
|
BR9916327A
(pt)
*
|
1998-12-17 |
2001-09-18 |
Hoffmann La Roche |
Oxindóis de 4-alquenila (e alquinila) como inibidores de cinases dependentes de ciclina, em particular, cdk2
|
|
CN1158283C
(zh)
|
1998-12-17 |
2004-07-21 |
霍夫曼-拉罗奇有限公司 |
作为蛋白激酶抑制剂的4-和5-吡嗪基羟吲哚
|
|
EP1149093A1
(en)
|
1998-12-17 |
2001-10-31 |
F. Hoffmann-La Roche Ag |
4-aryloxindoles as inhibitors of jnk protein kinases
|
|
JP4865129B2
(ja)
|
1999-01-13 |
2012-02-01 |
ザ・リサーチ・ファウンデーション・オブ・ステイト・ユニバーシティ・オブ・ニューヨーク |
タンパク質キナーゼ阻害剤を設計するための新規の方法
|
|
US7070936B1
(en)
|
1999-01-13 |
2006-07-04 |
The Research Foundation Of State University Of New York |
Method for designing protein kinase inhibitors
|
|
RU2271825C2
(ru)
*
|
1999-07-21 |
2006-03-20 |
Омерос Корпорейшн |
Растворы и способы ингибирования боли, воспаления и разрушения хряща
|
|
US6313310B1
(en)
|
1999-12-15 |
2001-11-06 |
Hoffmann-La Roche Inc. |
4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
|
|
EP1875900A3
(en)
*
|
2000-01-24 |
2010-07-21 |
Genzyme Corporation |
JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis
|
|
IL150763A0
(en)
*
|
2000-01-24 |
2003-02-12 |
Genzyme Corp |
Jak/stat inhibitors and pharmaceutical compositions containing the same
|
|
EP1275398A4
(en)
*
|
2000-04-06 |
2004-09-01 |
Kyowa Hakko Kogyo Kk |
DIAGNOSTIC AND MEDICINAL PRODUCTS FOR TREATING RHEUMATOID ARTHRITES
|
|
US7067550B2
(en)
*
|
2000-11-03 |
2006-06-27 |
Massachusetts Institute Of Technology |
Treatments for neurotoxicity in Alzheimer's Disease
|
|
EP1341548A4
(en)
*
|
2000-11-03 |
2006-06-14 |
Massachusetts Inst Technology |
METHOD FOR IDENTIFYING TREATMENTS AGAINST NEUROTOXICITY IN ALZHEIMER DISEASE CAUSED BY $ g (b) -AMYLOIDPEPTIDE
|
|
WO2003000188A2
(en)
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel quinazolines and uses thereof
|
|
US7129225B2
(en)
*
|
2001-10-22 |
2006-10-31 |
The Research Foundation Of State University Of New York |
Protection against and treatment of hearing loss
|
|
US7005445B2
(en)
*
|
2001-10-22 |
2006-02-28 |
The Research Foundation Of State University Of New York |
Protein kinase and phosphatase inhibitors and methods for designing them
|
|
ATE361746T1
(de)
*
|
2002-03-06 |
2007-06-15 |
Medical Res And Education Trus |
Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
|
|
US6924285B2
(en)
|
2002-03-30 |
2005-08-02 |
Boehringer Ingelheim Pharma Gmbh & Co. |
Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
|
|
GB0309850D0
(en)
|
2003-04-30 |
2003-06-04 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
WO2005003765A1
(en)
*
|
2003-06-30 |
2005-01-13 |
Astrazeneca Ab |
Isothermal titration calorimetry assays
|
|
GB0326459D0
(en)
|
2003-11-13 |
2003-12-17 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
WO2006007664A1
(en)
*
|
2004-07-22 |
2006-01-26 |
Genomics Research Partners Pty Ltd |
Agents and methods for diagnosing osteoarthritis
|
|
US8697139B2
(en)
|
2004-09-21 |
2014-04-15 |
Frank M. Phillips |
Method of intervertebral disc treatment using articular chondrocyte cells
|
|
EP1838712B8
(en)
|
2004-12-14 |
2011-10-12 |
AstraZeneca AB |
Pyrazolopyrimidine compounds as antitumor agents
|
|
DE102005005274A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Peter Heger |
Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und Behandlung chronisch-entzündlicher Erkrankungen
|
|
WO2007034144A1
(en)
|
2005-09-20 |
2007-03-29 |
Astrazeneca Ab |
4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
|
|
ES2369739T3
(es)
*
|
2006-03-20 |
2011-12-05 |
Seikagaku Corporation |
Agente terapéutico para la artritis reumatoide.
|
|
US7838542B2
(en)
*
|
2006-06-29 |
2010-11-23 |
Kinex Pharmaceuticals, Llc |
Bicyclic compositions and methods for modulating a kinase cascade
|
|
EP1921070A1
(de)
|
2006-11-10 |
2008-05-14 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
|
|
EP2118075A1
(de)
|
2007-02-06 |
2009-11-18 |
Boehringer Ingelheim International GmbH |
Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
WO2009026705A1
(en)
*
|
2007-08-24 |
2009-03-05 |
The University Of Western Ontario |
Method of diagnosing and treating osteoarthritis
|
|
CA2711582A1
(en)
|
2008-02-07 |
2009-08-13 |
Boehringer Ingelheim International Gmbh |
Spirocyclic heterocycles, formulations containing said compounds, use thereof and processes for the preparation thereof
|
|
EP2303276B1
(en)
|
2008-05-13 |
2013-11-13 |
AstraZeneca AB |
Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline
|
|
CN101396369B
(zh)
*
|
2008-08-07 |
2010-12-01 |
杜宁 |
槐角苷的制药应用
|
|
CA2733153C
(en)
|
2008-08-08 |
2016-11-08 |
Boehringer Ingelheim International Gmbh |
Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
|